EOS Med Chem, Medchem is Big
執大象，天下往，往而無害，安平泰
郵箱: gutian@eosmedchem.com; eosmedchem@gmail.com
辦公室: 0086-531-69905422-806(直通)
攜帶番號 & WhatsApp: +8618653174435
Skype: willgutian
| 药名 | CAS号 | 名称 | 结构式 |
| Momelotinib (CYT387)是一种ATP竞争性JAK1/JAK2抑制剂，IC50为11 nM/18 nM，比作用于JAK3选择性约高10倍左右。Phase 3。 | 1056634-68-4 | N-(cyanomethyl)-4-(2-((4-morpholinophenyl)amino)pyrimidin-4-yl)benzamide | 
|
| Firategrast 是口服生物相容性的α4β1/α4β7整合蛋白拮抗剂。 | 402567-16-2 | (S)-2-(2,6-difluorobenzamido)-3-(4'-(ethoxymethyl)-2',6'-dimethoxy-[1,1'-biphenyl]-4-yl)propanoic acid | 
|
| MK-2206 MK-2206双盐酸盐是 Akt1/2/3的高选择性抑制剂，IC50分别为8 nM，12 nM和65 nM，并且对已测的250种蛋白酶无抑制性。 | 1032349-93-1 | 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl[1,2,4]triazolo[3,4-f]-1,6-naphthyridin-3-ol | 
|
| ARN-509 ARN-509是竞争性雄激素受体抑制剂，IC50为16 nM，可作用于前列腺癌 | 956104-40-8 | 4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluoro-N-methylbenzamide | 
|
| JNJ-38877605 是ATP竞争性c-Met抑制剂，IC50为4 nM，对c-Met的抑制性比对其它200种酪氨酸和丝氨酸-苏氨酸激酶的抑制性要强600倍。 | 943540-75-8 | 6-{Difluoro[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline | 
|
| Cilomilast (SB 207499; Ariflo)是PDE4抑制剂，IC50为110 nM，有抗炎活性 | 153259-65-5 | 4-cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexane-1-carboxylic acid | 
|
RepSox E-616452; SJN 2511)是TGFβR-1/ALK5抑制剂，对ATP与ALK5的结合及ALK5的自磷酸化的IC50分别为23 nM和4 nM。 | 446859-33-2 | 2-(3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine | 
|
| SB-431542 是有效的，选择性的ALK5抑制剂，IC50为94 nM，也抑制Smad3磷酸化，IC50为94 nM | 301836-41-9 | 4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide | 
|
| Broxaterol(β2-受体激动剂) β受体激动剂包括非选择性的β受体激动剂如异丙肾上腺素及选择性心脏β1受体激动剂如多巴酚丁胺，选择性β2受体激动剂如沙丁胺醇、叔丁、喘宁等。 | 76596-57-1 | (1-(3-bromoisoxazol-5-yl)-2-(tert-butylamino)ethan-1-ol) | 
|
| 福莫特罗 是一种长效的选择性肾上腺素β2受体激动药，具有支气管扩张作用，且呈剂量依赖关系。能使第1秒用力呼气量(FEV1)、用力肺活量(FVC)和呼气峰流速(PER)增加 | 73573-87-2 | (R,R)-formoterol | 
|
| haloprogin 一种外用抗真菌、抗念珠菌和抗细菌的广谱抗菌药 | 777-11-7 | 1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene | 
|
| SR 3677 SR-3677是ROCK-II抑制剂，IC50为3 nM，对ROCK-I的IC50为56 nM | 1072959-67-1 | N-(2-(2-(dimethylamino)ethoxy)-4-(1H-pyrazol-4-yl)phenyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide | 
|
| JK184 是一种有效的Hedgehog（Hh）抑制剂，IC50为30 nM | 315703-52-7 | N-(4-ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)thiazol-2-amine | 
|
| Thiazovivin (Tzv) 是新型的ROCK抑制剂，IC50为0.5 μM，能促进hESC的存活 | 1226056-71-8 | N-Benzyl-2-(4-pyrimidinylamino)-1,3-thiazole-4-carboxamide | 
|
| Picumeterol (吡库特罗)支气管扩张药 | 130641-36-0 | (R)-1-(4-amino-3,5-dichlorophenyl)-2-((6-(2-(pyridin-2-yl)ethoxy)hexyl)amino)ethan-1-ol | 
|
| Bay 41-4109 racemate BAY 41-4109 racemate是人乙型肝炎病毒HBV的有效抑制剂，IC50值为53 nM | 298708-81-3 | methyl (R)-4-(2-chloro-4-fluorophenyl)-2-(3,5-difluoropyridin-2-yl)-6-methyl-1,4-dihydropyrimidine-5-carboxylate | 
|
| Y-27632 Y-27632双盐酸盐是ROCK1（p160ROCK）抑制剂，Ki为140 nM，比对PKC，cAMP-依赖的蛋白激酶，MLCK和PAK的抑制性高超过200倍。 | 146986-50-7 | (1R,4r)-4-((R)-1-aminoethyl)-N-(pyridin-4-yl)cyclohexane-1-carboxamide | 
|
| BMS-754807 BMS-754807是可逆的IGF-1R/InsR抑制剂，IC50分别为1.8 nM/1.7 nM，对Met，Aurora A/B，TrkA/B和Ron的抑制性较弱，对Flt3，Lck，MK2，PKA和PKC几乎无活性。 | 1001350-96-4 | (S)-1-(4-((5-cyclopropyl-1H-pyrazol-3-yl)amino)pyrrolo[2,1-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamide | 
|
| CHIR-99021 CHIR-99021 (CT99021)是GSK-3α和β抑制剂，IC50分别为10 nM和6.7 nM，比对CDC2，ERK2及其他激酶的抑制性强500倍。 | 252917-06-9 | 6-((2-((4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile | 
|
| A939572 A939572是口服生物相容性的SCD1抑制剂，对mSCD1和hSCD1的IC50分别为<4 nM和37 nM。 | 1032229-33-6 | 4-(2-chlorophenoxy)-N-(3-(methylcarbamoyl)phenyl)piperidine-1-carboxamide | 
|
| GSK429286A GSK429286A是ROCK1和ROCK2的选择性抑制剂，IC50分别为14 nM和63 nM。 | 864082-47-3 | N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-(4-(trifluoromethyl)phenyl)-1,4,5,6-tetrahydropyridine-3-carboxamide | 
|
| BI-D1870 是ATP竞争性S6核糖体抑制剂，对RSK1/2/3/4的IC50分别为31 nM/24 nM/18 nM/15 nM，比对MST2，GSK-3β，MARK3，CK1 和Aurora B的抑制性高10到100倍。 | 501437-28-1 | 2-((3,5-difluoro-4-hydroxyphenyl)amino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one | 
|
| LDN193189 LDN193189(DM 3189)是BMP信号转导抑制剂，对ALK2和ALK3的IC50分别为5 nM和30 nM，比对TGF-β的抑制性高200倍。 | 1062368-24-4 | 4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 
|
| GSK1059615 GSK1059615是可逆的PI3Kα/β/δ/γ和mTOR双重抑制剂，IC50为0.4 nM/0.6 nM/2 nM/5 nM和12 nM。 | 958852-01-2 | (Z)-5-((4-(pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione | 
|
| Robotnikinin | 1132653-79-2 | N-(4-chlorobenzyl)-2-((2R,6S,E)-5,12-dioxo-2-phenyl-1-oxa-4-azacyclododec-8-en-6-yl)acetamide | 
|
| HesperadinHesperadin是ATP竞争性Aurora B抑制剂，IC50为250 Nm | 422513-13-1 | N-[(3Z)-2-Oxo-3-(phenyl{[4-(1-piperidinylmethyl)phenyl]amino}methylen)-2,3-dihydro-1H-indol-5-yl]ethansulfonamid | 
|
| 1455087-30-5 | 3-(1-cyano-4-hydroxy-7-(4methoxyphenoxy)isoquinoline-3-carboxamido)-3-methylbutanoic acid | 
|
|
| 497172-36-8 | 2,6-bis((4S,5R)-4,5-diphenyl-4,5-dihydrooxazol-2-yl)pyridine | 
|
|
| 176672-06-3 | 
|
||
| 3-Bromo-6-methoxy-2-(4-methoxyphenyl)-1-benzothiophene | 
|
||
| methyl (R)-2-amino-3-(4'-(ethoxymethyl)-2',6'-dimethoxy-[1,1'-biphenyl]-4-yl)propanoate | 
|
||
| (S)-2-(4-(3-aminopropoxy)-2,6-dichlorobenzamido)-3-(4-(2,6-dichlorobenzamido)phenyl)propanoic acid | 
|
||
| tert-butyl ((S)-1-(((S)-1-cyclohexyl-2-((S)-2-(4-(3-hydroxybenzoyl)thiazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)amino)-1-oxopropan-2-yl)(methyl)carbamate | 
|
||
|
|||
| 152013-26-8 | N-methyl-2-(4-methyl-1,4-diazepan-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carboxamide | 
|
|
| 105331-00-8 | 4,6-Diamino-1-(β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one | 
|
|
| 6-(4-(1,3-difluoropropan-2-yl)-4H-1,2,4-triazol-3-yl)pyridin-2-amine | 
|
||
| 13-(1-(3-(2-((2-(((9H-fluoren-9-yl)methoxy)carbonyl)-1,2- dimethylhydrazinyl)methyl)-1H-indol-1-yl)propanoyl)piperidin-4-yl)-2,2-dimethyl-4,14- dioxo-3,7,10-trioxa-13-azaheptadecan-17-oic acid (Fmoc-HIPS-PAPip(PEG2(CO2t- Bu))CO2H) | 
|
||
| 2-(4-(2-(((1R,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl)amino)ethyl)phenoxy)acetic acid | 
|
||
| 2-(4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)-2-fluorophenyl)acetic acid | 
|
||
| methyl 3-(3-nitrophenoxy)propanoate | 
|
||
| 2-hydroxy-N-(3-methoxy-4-nitrophenethyl)acetamide | 
|
||
| 1225584-97-3 | 3-((4-(1-ethyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-yl)amino)benzenesulfonamide | 
|
|
| 115935-89-2 | (3R,4R)-3-benzyloxycarbonylamino-4-hydroxymethyl-2-oxoazetidine-1-sulphonic acid tetrabutylammonium salt | 
|
|
| 5-benzyl -4-methyl (3aR,4S,6aR)-2,2-dimethylhexahydro-5H-furo[2,3-c]pyrrole-4,5-dicarboxylate | 
|
||
| N-(4,5-dimethoxy-2-nitrobenzyl)-N-(4-hydroxy-3-methoxybenzyl)nonanamide | 
|
||
| N-(4-((1H-imidazol-2-yl)carbamoyl)-1H-benzo[d]imidazol-2-yl)isoquinoline-3-carboxamide | 
|
||
| 64544-01-0 | 7-bromo-6-chloro-3-(3-(3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one (halofuginone) | 
|
|
| 1204317-86-1 | 2-amino-N-(2-((4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenamido)ethyl)benzamide | ||
| 1052709-68-8 | (S)-3-amino-N-(4-(3-aminopiperidin-1-yl)pyridin-3-yl)-6-(2-fluorophenyl)picolinamide | 
|
|
| (S)-3-amino-N-(4-(3-aminopiperidin-1-yl)pyridin-3-yl)-6-(5-(dimethylcarbamoyl)-2-fluorophenyl)picolinamide | 
|
||
| 1224936-48-4 | 1-(2,6-dimethylmorpholino)-3-(3-fluorophenoxy)propan-2-ol | 
|
|
| 1228216-68-9 | 1-(4-((4-methoxybenzoyl)oxy)phenethyl)-2-(4-(trifluoromethyl)benzamido)-1H-benzo[d]imidazole-5-carboxylic acid | 
|
|
| 1263101-80-9 | 5-(3,3-dimethyl-but-1-ynyl)-3-(1,4-dioxa-spiro[4.5]dec-8-ylamino)-thiophene-2-carboxylic acid methyl ester | 
|
|
| 582316-00-5 | 3-({N-[(Benzyloxy)Carbonyl]-L-Valyl}Amino)-5-Fluoro-4-Oxopentanoic Acid | 
|
|
| 1228445-38-2 | N-(Cyclopropylmethyl)-4-{[4-(6-hydroxy-3,4-dihydro-1(2H)-quinolinyl)-2-pyrimidinyl]amino}benzenesulfonamide | 
|
|
| 1449425-49-3 | 5-(4-cyanobenzyl)-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carboxylic acid | 
|
|
| 1225586-11-7 | N-(4-methyl-3-(morpholinosulfonyl)phenyl)-4-(1-propyl-1H-pyrrolo[2,3-c]pyridin-3-yl)pyrimidin-2-amine | 
|
|
| 134098-68-3 | 3-(2'-acetoxy-4',6'-dimethylphenyl)-3,3-dimethylpropanoic acid | 
|
|
| 239066-73-0 | 5-allyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-f]quinoline | 
|
|
| 136529-69-6 | 1-acetoxy-4-(1-chloro-2-methylamino-ethyl)-benzene | 
|
|
| 1-(4-hydroxyphenethyl) 5-methyl (S)-3-(2-methoxy-2-oxoacetamido)pentanedioate | 
|
||
| 1070892-92-0 | 4-chloro-5-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-2-methoxy-benzoic acid | 
|
|
| 1032350-06-3 | [1-(4-bromophenyl)cyclobutyl]carbamic acid tert-butyl ester | 
|
|
| 5-((furan-2-ylmethyl)amino)-3-(4-methylpiperazin-1-yl)-6H-anthra[1,9-cd]isoxazol-6-one | 
|
||
| 871726-72-6 | tert-butyl (Z)-4-((dimethylamino)methylene)-3-oxopiperidine-1-carboxylate | 
|
|
| (S)-3,9-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquinolino[3,2-a]isoquinoline-2,10-diyl diacetate | 
|
||
| tert-butyl 4-(2-chloro-4-fluorophenyl)-6-methyl-2-(thiazol-2-yl)-1,4-dihydropyrimidine-5-carboxylate | 
|
||
| 892242-64-7 | 4-((3-(4-cyclohexylpiperazin-1-yl)-6-oxo-6H-anthra[1,9-cd]isoxazol-5-yl)amino)benzoic acid | 
|
|
| (E)-5-(4-((3-chloro-4-fluorophenyl)imino)-3-methyl-3,4-dihydroquinazolin-6-yl)pyrimidin-2-amine | 
|
||
| N-(3-(5-chloro-2-((3-(piperazin-1-yl)phenyl)amino)pyrimidin-4-yl)phenyl)acrylamide | 
|
||
| N-(3-(5-chloro-2-((3-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-5-methylphenyl)acrylamide | 
|
||
| 4-(3-mesitylisoxazol-5-yl)benzenesulfonamide | 
|
||
| 1-(3-(4-(furan-2-carbonyl)piperazin-1-yl)propyl)-4,9-dioxo-4,9-dihydro-1H-naphtho[2,3-d][1,2,3]triazole 2-oxide | 
|
||
| (E)-5-(4-((3-chloro-4-fluorophenyl)imino)-3-methyl-3,4-dihydroquinazolin-6-yl)pyrimidin-2-amine | 
|
||
| (E)-5-(3-methyl-4-((3-(trifluoromethyl)phenyl)imino)-3,4-dihydroquinazolin-6-yl)pyrimidin-2-amine | 
|
||
| 1003602-79-6 | 2-((2-fluoro-5-methoxyphenyl)amino)-4-((2-(N-methylmethylsulfonamido)phenyl)amino)pyrimidine-5-carboxamide | 
|
|
| 1391054-73-1 | (6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-7-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone | 
|
|
| MK-2206 MK-2206双盐酸盐是 Akt1/2/3的高选择性抑制剂，IC50分别为8 nM，12 nM和65 nM，并且对已测的250种蛋白酶无抑制性。 | 1032350-13-2 | MK-2206 dihydrochloride | 
|
| 956907-27-0 | 6-[(6-Bromo-1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)methyl]-7-fluoroquinoline | 
|
|
|
|||
| Cdk1 Inhibitor | 190653-73-7 | [(1R,2S)-2-aminocyclohexyl]-[6-[(3-chlorophenyl)amino]-9-ethyl-purin-2-yl]amine | 
|
| 444722-95-6 | 4-{[6-(Cyclohexylmethoxy)-1H-purin-2-yl]amino}benzenesulfonamide | 
|
|
| 1421227-53-3 | N-(6-{4-[2-({4-[(4-Methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl}amino)-2-oxoethyl]phenoxy}-4-pyrimidinyl)cyclopropanecarboxamide | 
|
|
| 1096770-84-1 | [4-(Tetradecanoylamino)benzyl]phosphonic acid | 
|
|
| 154447-35-5 | 2-(morpholin-4-yl)benzo(h)chromen-4-one | 
|
|
| 1258275-73-8 | Ethyl (2,3,4-trimethoxy-6-octanoylphenyl)acetate | 
|
|
| 1388841-50-6 | 2-[(Z)-2-{3-[3,5-Bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}vinyl]-1,3,4-oxadiazole | 
|
|
| 76931-93-6 | S-{2-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-2-oxoethyl} ethanethioate | 
|
|
| 1144035-53-9 | 3,5-Dichlorobenzyl 4-[3-oxo-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)propyl]-1-piperazinecarboxylate | 
|
|
| 146986-50-7 | 4-[(1R)-1-Aminoethyl]-N-(4-pyridinyl)cyclohexanecarboxamide | 
|
|
|
|||
| N-{6-[(2-Amino-4-fluorophenyl)amino]-6-oxohexyl}-4-methylbenzamide | 
|
||
| 849234-64-6 | 4-Acetamido-N-[2-amino-5-(2-thienyl)phenyl]benzamide | 
|
|
| N-[2-Amino-5-(2-thienyl)phenyl]-6-(1-oxo-2,7-diazaspiro[3.5]non-7-yl)nicotinamide | 
|
||
| N-[2-Amino-5-(2-thienyl)phenyl]-6-(2,8-diazaspiro[4.5]dec-8-yl)nicotinamide | 
|
||
| SB 203580 | 152121-47-6 | 4-(4-(4-fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-5-yl)pyridine | 
|
| 245747-08-4 | N-{4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}-3-fluoroisonicotinamide | 
|
|
| 1315323-00-2 | N-{4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}-4-methylbenzenesulfonamide | 
|
|
| 68550-75-4 | N-cyclohexyl-4-[(2-hydroxyquinolin-6-yl)oxy]-N-methylbutanamide | 
|
|
| 99590-86-0 | Bis(acetoxymethyl) 3,12-bis[2-(acetoxymethoxy)-2-oxoethyl]-6,9-dioxa-3,12-diazatetradecane-1,14-dioate | 
|
|
| 1618672-71-1 | 1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene | 
|
|
| 1,3-Bis(3,5-dichlorophenyl)urea | 
|
||
| Ethyl 4-{[(3,5-dichlorophenyl)carbamothioyl]amino}-1-piperidinecarboxylate | 
|
||
| 204521-63-1 | (S)-1-tert-butyl 5-(2,5-dioxopyrrolidin-1-yl) 2-palmitamidopentanedioate | 
|
|
| {[1-(4-Aminobutanoyl)-5,7-dinitro-2,3-dihydro-1H-indol-4-yl]oxy}acetic acid | 
|
||
| 674799-96-3 | 6-{[4-(Aminomethyl)benzyl]oxy}-3H-purin-2-amine | 
|
|
| 1235481-90-9 | N-[3-(3,6-Dibromo-9H-carbazol-9-yl)-2-fluoropropyl]-3-methoxyaniline | 
|
|
| 475479-10-8 | Methyl (2E)-3-methoxy-2-{2-[(6-methoxy-4-pyrimidinyl)oxy]phenyl}acrylate | 
|
|
| 131860-97-4 | Methyl (2E)-2-{2-[(6-chloro-4-pyrimidinyl)oxy]phenyl}-3-methoxyacrylate | 
|
|
| azoxystrobin | 131860-97-4 | (2E)-2-(2-{[6-(2-Cyanophénoxy)-4-pyrimidinyl]oxy}phényl)-3-méthoxyacrylate de méthyle | 
|
| N-(4-{[(3,5-dimethylanilino)carbonyl]amino}phenyl)-2-hydroxybenzamid | 
|
||
| 1164486-69-4 | (2E)-N-(4,6-Dimethyl-2-pyridinyl)-3-(2-thienyl)acrylamide | 
|
|
| N-[4-(Difluoromethoxy)phenyl]-2-[(4-oxo-6-propyl-1,4-dihydro-2-pyrimidinyl)sulfanyl]acetamide | 
|
||
| CID-16020046 | 834903-43-4 | 4-[4-(3-Hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl]benzoic acid | 
|
| 371242-69-2 | 2-[(6-Amino-9H-purin-9-yl)methyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone | 
|
|
| 20904-83-6 | 5-iodo-3-((3,5-dibromo-4-hydroxyphenyl)methylene)-2-indolinone | 
|
|
| 1255517-77-1 | 2-Cyclohexyl-N-(1-isopropyl-4-piperidinyl)-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinamine | 
|
|
| 396129-53-6 | 4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]quinoline | 
|
|
| 41609-06-7 | 2-(Benzylamino)-4,4-dimethyl-6-oxo-N-phenyl-1-cyclohexene-1-carbothioamide | 
|
|
| 566914-00-9 | N-[(2S)-3-Methyl-1-oxo-1-(1-pyrrolidinyl)-2-butanyl]-3-phenylpropanamide | 
|
|
| 1253491-42-7 | 6-Methoxy-1-(1-naphthyl)-9H-β-carboline | 
|
|
|
|||
|
|||
|
|||
| 1169755-45-6 | (1Z)-1-(3-Ethyl-5-hydroxy-1,3-benzothiazol-2(3H)-ylidene)acetone | 
|
|
| 950912-80-8 | 4-[1-Cyclohexyl-4-(4-fluorophenyl)-1H-imidazol-5-yl]-2-pyrimidinamine dihydrochloride | 
|
|
| 4-[4-(1,3-Benzodioxol-5-yl)-5-(6-methyl-2-pyridinyl)-1H-imidazol-2-yl]bicyclo[2.2.2]octane-1-carboxamide | 
|
||
| 7-[4-(Dimethylamino)butoxy]-6-methoxy-2-(4-methyl-1,4-diazepan-1-yl)-N-(1-methyl-4-piperidinyl)-4-quinazolinamine | 
|
||
6-Methoxy-2-(4-methyl-1,4-diazepan-1-yl)-N-(1-methyl-4-piperidinyl)-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinamine | 
|
||
| 935693-62-2 | N-(1-Benzyl-4-piperidinyl)-6,7-dimethoxy-2-(4-methyl-1,4-diazepan-1-yl)-4-quinazolinamine | 
|
|
|
|||
|
|||
|
|||
|
|||
| 674799-96-3 | 6-{[4-(Aminomethyl)benzyl]oxy}-3H-purin-2-amine | 
|
|
|
|||
1268865-07-1 | Methyl 3-oxo-2-phenyl-3,4-dihydro-6-quinoxalinecarboxylate | 
|
|
| 848144-15-0 | N-{2-Methoxy-5-(2-methyl-2-propanyl)-3-[(methylsulfonyl)amino]phenyl}-2-{4-[2-(4-morpholinyl)ethoxy]-1-naphthyl}-2-oxoacetamide | 
|
|
| seriniquinone | 
|
||
| {[1-(4-Aminobutanoyl)-5,7-dinitro-2,3-dihydro-1H-indol-4-yl]oxy}acetic acid | 
|
||
| [3-({4-[(2-Methyl-2-propanyl)oxy]phenoxy}methyl)-3,4-dihydro-2(1H)-isoquinolinyl](1-naphthyl)methanone | 
|
||
| 914471-09-3 | 4-Amino-N-(3-chloro-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide | 
|
|
| 1383701-59-4 | Methyl 2-oxo-3-phenyl-1,2-dihydro-6-quinoxalinecarboxylate | 
|
|
| 475479-10-8 | Methyl (2E)-3-methoxy-2-{2-[(6-methoxy-4-pyrimidinyl)oxy]phenyl}acrylate | 
|
|
N-(4-{[(3,5-dimethylanilino)carbonyl]amino}phenyl)-2-hydroxybenzamide | 
|
||
2-{2-[(3,5-Dimethylphenyl)amino]-4-pyrimidinyl}-N-[(2S)-1-hydroxy-2-propanyl]-4-methyl-1,3-thiazole-5-carboxamide | 
|
||
| 284028-89-3 | 2-[4-(trifluoromethyl)phenyl]-7,8-dihydro-5H-thiino[4,3-d]pyrimidin-4-ol | 
|
|
| 163655-37-6 | (3E)-3-{[4-(Dimethylamino)-1-naphthyl]methylene}-1,3-dihydro-2H-indol-2-one | 
|
|
| Zebularine(NSC309132; 4-Deoxyuridine)是DNA甲基化抑制剂，能与DNA甲基化酶共价结合，也能抑制Cytidinedeaminase酶活性，Ki值为2uM。 | 654065 | Zebularine | 
|
| 220904-83-6 | (Z)-3-(3,5-dibromo-4-hydroxybenzylidene)-5-iodoindolin-2-one | 
|
|
| 1643657-35-5 | 1,3-Benzodioxol-5-ylmethyl 6-(4-biphenylyl)hexanoate | 
|
|
| 101314-97-0 | 辛伐他汀杂质A Sodium (3R,5R)-7-{(1S,2S,6R,8S,8aR)-8-[(2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydro-1-naphthalenyl}-3,5-dihydroxyheptanoate | 
|
